Town Hall Resources

The following list of references has been provided by Adele Framer, Will Hall, David Healy and Nicole Lamberson to accompany our town hall discussion held on May 14, 2021. Click here to find general support resources.

Selected Research Papers and Links

From Adele Framer

Hengartner, M. P., Schulthess, L., Sorensen, A., & Framer, A. (2020). Protracted withdrawal syndrome after stopping antidepressants: A descriptive quantitative analysis of consumer narratives from a large internet forum. Therapeutic Advances in Psychopharmacology

Framer, A. (2021). What I have learnt from helping thousands of people to taper off antidepressants and other psychotropic medications. Therapeutic Advances in Psychopharmacology

Lerner, A., & Klein, M. (2019). Dependence, withdrawal and rebound of CNS drugs: An update and regulatory considerations for new drugs development. Brain Communications1(1).

SAMHSA. (2010). Protracted Withdrawal (Substance Abuse Treatment Advisory Volume 9, Issue 1; p. 8). SAMHSA Center for Substance Abuse Treatment.

Brower, K. J., & Perron, B. E. (2010). Sleep disturbance as a universal risk factor for relapse in addictions to psychoactive substances. Medical Hypotheses74(5), 928–933.

Chouinard, G., & Chouinard, V.-A. (2015). New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal. Psychotherapy and Psychosomatics84(2), 63–71.

Davies, J., & Read, J. (2019). A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based? Addictive Behaviors, S0306460318308347.

Honig, J. (2021, February 21). Online Experts on Withdrawal. Mad In America

Horowitz, M. A., & Taylor, D. (2019). Tapering of SSRI treatment to mitigate withdrawal symptoms. The Lancet Psychiatry6(6), 538–546.

Leeuwen, E. van, van Driel, M., De Sutter, A., Robertson, L., Kendrick, T., Horowitz, M., Donald, M., & Christiaens, T. (2021). Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults (Review). Cochrane Database of Systematic Reviews

Read, J. (2020). Withdrawal From Antidepressants: A Review. Psychology Today

White, E. (2021, March 23). Tapering antidepressants: Why do tens of thousands of people turn to Facebook groups for support? | BJGP Life

Therapeutic Advances in Psychopharmacology Special Collection Discontinuing Psychotropic Medication.

Horowitz, Mark Abie, Robin M. Murray, and David Taylor. “Tapering Antipsychotic Treatment.” JAMA Psychiatry, August 5, 2020.

Horowitz, Mark Abie, and David Taylor. “Tapering of SSRI Treatment to Mitigate Withdrawal Symptoms.” The Lancet Psychiatry 6, no. 6 (June 2019): 538–46.

Chouinard, Guy, and Virginie-Anne Chouinard. “New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal.” Psychotherapy and Psychosomatics 84, no. 2 (February 21, 2015): 63–71.

Kotzalidis, Giorgio D., Barbara Patrizi, Saverio Simone Caltagirone, Alexia Koukopoulos, Valeria Savoja, Gaia Ruberto, Caterina Tatarelli, et al. “The Adult SSRI/SNRI Withdrawal Syndrome: A Clinically Heterogeneous Entity.” Clinical Neuropsychiatry 4, no. 2 (April 2007): 61–75.

From Will Hall

More information on the Maastricht antipsychotic withdrawal study and Will’s free withdrawal guide –

From Nicole Lamberson

Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications –

Response to the above article by Dr. Christy Huff –

W-BAD World Benzodiazapine Awareness Day. (2020). PROTRACTED WITHDRAWAL SYNDROME (PWS). World Benzodiazapine Awareness Day July 11

From David Healy


Post-SSRI Sexual Dysfunction (PSSD) –